Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters
ObjectiveNeuropathic pain (NP) may influence disease activity assessment in patients with psoriatic arthritis, this relationship being traditionally based on the presence of concomitant fibromyalgia. We analyzed the influence of other comorbidities on NP and the relationship between pain and various...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1331761/full |
| _version_ | 1797347924091338752 |
|---|---|
| author | Esther Toledano Rubén Queiro Luis Gómez-Lechón Carolina Cristina Chacón Cristina Hidalgo Marta Ibañez Agustín Díaz-Álvarez Carlos Montilla |
| author_facet | Esther Toledano Rubén Queiro Luis Gómez-Lechón Carolina Cristina Chacón Cristina Hidalgo Marta Ibañez Agustín Díaz-Álvarez Carlos Montilla |
| author_sort | Esther Toledano |
| collection | DOAJ |
| description | ObjectiveNeuropathic pain (NP) may influence disease activity assessment in patients with psoriatic arthritis, this relationship being traditionally based on the presence of concomitant fibromyalgia. We analyzed the influence of other comorbidities on NP and the relationship between pain and various clinical parameters.MethodsA cross-sectional study was conducted in patients diagnosed with psoriatic arthritis, excluding patients with a previous diagnosis of fibromyalgia, depression, anxiety, diabetes and/or dyslipidemia under treatment. NP was identified using the painDETECT questionnaire (score > 18). Obesity and related clinical parameters, anxious and depressive symptoms, sleep quality and fatigue were assessed as comorbidities. Disease activity was measured using the clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA) in peripheral involvement, the ASDAS-PCR in axial involvement, functioning and disease impact were measured using the Health Assessment Questionnaire-Disability Index and 12-item Psoriatic Arthritis Impact of Disease questionnaire, respectively.ResultsOverall, 246 patients were included (136 men; 55%). The mean age was 53.4 ± 11.0 years. Forty-two patients had NP (17.1%). Patients with NP had higher leptin levels (OR: 1.03, 95% CI: 1.007–1.056; p < 0.01) and poor sleep quality (OR: 1.20, 95% CI: 1.09–1.297; p < 0.001). Patients with NP also had greater fatigue NRS (6.2 ± 2.2 vs. 2.4 ± 0.19, p < 0.001). Patients with NP had higher cDAPSA score (17.3 ± 5.4 vs. 8.9 ± 6.5, p < 0.001), poorer functioning (1.1 ± 0.5 vs. 0.4 ± 0.5, p < 0.001) and greater disease impact (6.1 ± 1.7 vs. 2.6 ± 1.9, p < 0.001).ConclusionNP was correlated with sleep quality and serum leptin and may be associated with worse disease activity, functioning and disease impact. |
| first_indexed | 2024-03-08T11:55:56Z |
| format | Article |
| id | doaj.art-f5b0d0034eec49258aa843b9d60ab86b |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-08T11:55:56Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-f5b0d0034eec49258aa843b9d60ab86b2024-01-24T04:38:26ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-01-011110.3389/fmed.2024.13317611331761Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parametersEsther Toledano0Rubén Queiro1Luis Gómez-Lechón2Carolina Cristina Chacón3Cristina Hidalgo4Marta Ibañez5Agustín Díaz-Álvarez6Carlos Montilla7Department of Rheumatology, Hospital Clínico Universitario San Carlos, Madrid, SpainDepartment Rheumatology, Hospital Universitario Central de Asturias, Oviedo, SpainDepartment of Rheumatology, Francesc De Borja Hospital, Gandía, SpainDepartment of Rheumatology, Hospital Universitario de Salamanca, Salamanca, SpainDepartment of Rheumatology, Hospital Universitario de Salamanca, Salamanca, SpainDepartment of Rheumatology, Hospital Universitario de Salamanca, Salamanca, SpainDepartment of Anesthesiology, Hospital Universitario de Salamanca, Salamanca, SpainDepartment of Rheumatology, Hospital Universitario de Salamanca, Salamanca, SpainObjectiveNeuropathic pain (NP) may influence disease activity assessment in patients with psoriatic arthritis, this relationship being traditionally based on the presence of concomitant fibromyalgia. We analyzed the influence of other comorbidities on NP and the relationship between pain and various clinical parameters.MethodsA cross-sectional study was conducted in patients diagnosed with psoriatic arthritis, excluding patients with a previous diagnosis of fibromyalgia, depression, anxiety, diabetes and/or dyslipidemia under treatment. NP was identified using the painDETECT questionnaire (score > 18). Obesity and related clinical parameters, anxious and depressive symptoms, sleep quality and fatigue were assessed as comorbidities. Disease activity was measured using the clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA) in peripheral involvement, the ASDAS-PCR in axial involvement, functioning and disease impact were measured using the Health Assessment Questionnaire-Disability Index and 12-item Psoriatic Arthritis Impact of Disease questionnaire, respectively.ResultsOverall, 246 patients were included (136 men; 55%). The mean age was 53.4 ± 11.0 years. Forty-two patients had NP (17.1%). Patients with NP had higher leptin levels (OR: 1.03, 95% CI: 1.007–1.056; p < 0.01) and poor sleep quality (OR: 1.20, 95% CI: 1.09–1.297; p < 0.001). Patients with NP also had greater fatigue NRS (6.2 ± 2.2 vs. 2.4 ± 0.19, p < 0.001). Patients with NP had higher cDAPSA score (17.3 ± 5.4 vs. 8.9 ± 6.5, p < 0.001), poorer functioning (1.1 ± 0.5 vs. 0.4 ± 0.5, p < 0.001) and greater disease impact (6.1 ± 1.7 vs. 2.6 ± 1.9, p < 0.001).ConclusionNP was correlated with sleep quality and serum leptin and may be associated with worse disease activity, functioning and disease impact.https://www.frontiersin.org/articles/10.3389/fmed.2024.1331761/fullpsoriatic arthritisneuropathic painsleep qualityanxietydepressionfatigue |
| spellingShingle | Esther Toledano Rubén Queiro Luis Gómez-Lechón Carolina Cristina Chacón Cristina Hidalgo Marta Ibañez Agustín Díaz-Álvarez Carlos Montilla Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters Frontiers in Medicine psoriatic arthritis neuropathic pain sleep quality anxiety depression fatigue |
| title | Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters |
| title_full | Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters |
| title_fullStr | Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters |
| title_full_unstemmed | Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters |
| title_short | Influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis: relationship with clinical parameters |
| title_sort | influence of comorbidities not associated with fibromyalgia on neuropathic pain in patients with psoriatic arthritis relationship with clinical parameters |
| topic | psoriatic arthritis neuropathic pain sleep quality anxiety depression fatigue |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2024.1331761/full |
| work_keys_str_mv | AT esthertoledano influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT rubenqueiro influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT luisgomezlechon influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT carolinacristinachacon influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT cristinahidalgo influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT martaibanez influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT agustindiazalvarez influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters AT carlosmontilla influenceofcomorbiditiesnotassociatedwithfibromyalgiaonneuropathicpaininpatientswithpsoriaticarthritisrelationshipwithclinicalparameters |